Moreover, our results showed that the decreased expression of CLDN10 was associated with increased infiltration of several major immune cells, potentially enhancing the body’s anti-tumor immune response, which partly explains why low expression of CLDN10 was associated with better prognosis in gastric cancer. Here, CLDN10 is linked to neoplasm.